We randomly allocated patients to topical treatment with either 1 % cidofovir ( supplied as a gel in a 10 g tube , to last 6 weeks ) or 5 % imiquimod ( one 250 mg sachet for every application ) , to be self-applied three times a week for a maximum of 24 weeks .